Terms: = Germ cell tumor AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Treatment
953 results:
1. Strategies to Improve Drug Delivery Across the Blood-Brain Barrier for Glioblastoma.
Narsinh KH; Perez E; Haddad AF; Young JS; Savastano L; Villanueva-Meyer JE; Winkler E; de Groot J
Curr Neurol Neurosci Rep; 2024 May; 24(5):123-139. PubMed ID: 38578405
[TBL] [Abstract] [Full Text] [Related]
2. Current outstanding challenges in germ cell tumors.
Salous T; Adra N
Curr Opin Oncol; 2024 May; 36(3):169-173. PubMed ID: 38573206
[TBL] [Abstract] [Full Text] [Related]
3. Clinical diagnosis and management of multiple cerebral ring-enhancing lesions-study of 50 patients at a tertiary healthcare center.
Patel A; More B; Rege I; Ranade D
J Cancer Res Ther; 2024 Jan; 20(1):112-117. PubMed ID: 38554307
[TBL] [Abstract] [Full Text] [Related]
4. Head and Neck Mucosal Melanoma: Where Are We Now?
Hanba C; Hanna E
Curr Oncol Rep; 2024 Apr; 26(4):421-425. PubMed ID: 38512416
[TBL] [Abstract] [Full Text] [Related]
5. Mechanism interpretation of Guhan Yangshengjing for protection against Alzheimer's disease by network pharmacology and molecular docking.
Cheung S; Zhong Y; Wu L; Jia X; He MQ; Ai Y; Jiao Q; Liang Q
J Ethnopharmacol; 2024 Jun; 328():117976. PubMed ID: 38492794
[TBL] [Abstract] [Full Text] [Related]
6. Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas.
Valerius AR; Webb MJ; Hammad N; Sener U; Malani R
Curr Oncol Rep; 2024 Apr; 26(4):377-390. PubMed ID: 38488990
[TBL] [Abstract] [Full Text] [Related]
7. Can we yet use tertiary lymphoid structures as predictive biomarkers for immunotherapy response in melanoma?
Padonou F; Vanhulst T; Langouo-Fontsa MD
Curr Opin Oncol; 2024 Mar; 36(2):63-68. PubMed ID: 38441065
[TBL] [Abstract] [Full Text] [Related]
8. Suppression of ITPKB degradation by Trim25 confers TMZ resistance in glioblastoma through ROS homeostasis.
Yan Y; Zhou S; Chen X; Yi Q; Feng S; Zhao Z; Liu Y; Liang Q; Xu Z; Li Z; Sun L
Signal Transduct Target Ther; 2024 Mar; 9(1):58. PubMed ID: 38438346
[TBL] [Abstract] [Full Text] [Related]
9. Lymph Node Dissection in Testicular Cancer: The State of the Art and Future Perspectives.
Małkiewicz B; Świrkosz G; Lewandowski W; Demska K; Szczepaniak Z; Karwacki J; Krajewski W; Szydełko T
Curr Oncol Rep; 2024 Apr; 26(4):318-335. PubMed ID: 38430323
[TBL] [Abstract] [Full Text] [Related]
10. Mechanistic study of the anti-excitatory amino acid toxicity of Bushen Zhichan decoction for Parkinson's disease based on the transcriptional regulation of EAAT1 by YY1.
Liu L; Tian X; Li W
J Ethnopharmacol; 2024 May; 325():117857. PubMed ID: 38350506
[TBL] [Abstract] [Full Text] [Related]
11. Testicular cancer with small metastatic burden: optimal approach in 2024.
Yuen KL; Pandit K; Puri D; Yodkhunnatham N; Bagrodia A
Curr Opin Urol; 2024 May; 34(3):204-209. PubMed ID: 38305430
[TBL] [Abstract] [Full Text] [Related]
12. Hypoxia-Inducible Factor-1α (HIF-1α) as a Factor to Predict the Prognosis of Spinal Chordoma.
He G; Liu X
Spine (Phila Pa 1976); 2024 May; 49(9):661-669. PubMed ID: 38251727
[TBL] [Abstract] [Full Text] [Related]
13. Single agent vs combination immunotherapy in advanced melanoma: a review of the evidence.
Benhima N; Belbaraka R; Langouo Fontsa MD
Curr Opin Oncol; 2024 Mar; 36(2):69-73. PubMed ID: 38193381
[TBL] [Abstract] [Full Text] [Related]
14. Impaired Aortic Growth in Neuroblastoma Patients After Intensive treatment.
Takenouchi A; Kudo W; Terui K; Komatsu S; Oita S; Yoshizawa H; Kawaguchi Y; Fumita T; Nishimura K; Hishiki T
J Pediatr Surg; 2024 Apr; 59(4):593-598. PubMed ID: 38184434
[TBL] [Abstract] [Full Text] [Related]
15. Updated Response Assessment in Neuro-Oncology (RANO) for Gliomas.
Youssef G; Wen PY
Curr Neurol Neurosci Rep; 2024 Feb; 24(2):17-25. PubMed ID: 38170429
[TBL] [Abstract] [Full Text] [Related]
16. Appendiceal Neuroendocrine Neoplasms: an Update for 2023.
Holmager P; Langer SW; Kjaer A; Ringholm L; Garbyal RS; Hansen CP; Andreassen M; Knigge U
Curr Oncol Rep; 2024 Feb; 26(2):114-120. PubMed ID: 38168835
[TBL] [Abstract] [Full Text] [Related]
17. A study on molecular mechanism of Xihuang pill in the treatment of glioblastoma based on network pharmacology and validation in vitro and in vivo.
Xu HB; Chen XZ; Zhu SY; Xue F; Zhang YB
J Ethnopharmacol; 2024 Apr; 323():117675. PubMed ID: 38159819
[TBL] [Abstract] [Full Text] [Related]
18. Long-Term Outcomes of Infantile Sacrococcygeal Teratoma: Results from a Multi-Institutional Retrospective Observational Study in Japan.
Fumino S; Hirohata Y; Takayama S; Tajiri T; Usui N; Taguchi T;
J Pediatr Surg; 2024 Apr; 59(4):587-592. PubMed ID: 38158258
[TBL] [Abstract] [Full Text] [Related]
19. Oncology for the rhinologist.
Tam K; Dunn LA; Cohen MA
Curr Opin Otolaryngol Head Neck Surg; 2024 Feb; 32(1):14-19. PubMed ID: 38116847
[TBL] [Abstract] [Full Text] [Related]
20. Neuroendocrine tumors' patients treated with somatostatin analogue could complicate with emergency cholecystectomy.
Calomino N; Poto GE; Carbone L; Bagnacci G; Piccioni S; Andreucci E; Nenci L; Marano L; Verre L; Petrioli R; Roviello F; Marrelli D
Ann Ital Chir; 2023; 94():518-522. PubMed ID: 38051513
[TBL] [Abstract] [Full Text] [Related]
[Next]
